National Procurement for HIV and Preventative Treatments
NHSE&I
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from NHSE&I, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
NHSE&I awarded this contract to Gilead Sciences Limited | Merck Sharpe & Dohme (UK) Limited | Janssen-Cilag Ltd | Amarox Limited | Tillomed Laboratories ltd | Glenmark Pharmaceuticals Europe Limited | Macleods Pharma UK Limited | ViiV Healthcare | Abbvie Ltd | Mylan | Mawdsley-Brooks & Co Ltd | Lupin Healthcare (UK) Limited | Teva UK Limited | Dr.Reddy's Laboratories (UK) Limited | Zentiva Pharma UK Ltd worth £230,000,000 on 1 Feb 2022. The contract runs until 31 Jul 2023.
Description
Lot 1 - supply of licensed antiretroviral therapy (ART) for the treatment of HIV
(Adults and Children) and licensed pre-exposure prophylaxis (PrEP) packs for
the prevention of HIV.
Lot 2 - a service to supply over labelled post-exposure prophylaxis (PEP)
packs for the prevention of HIV.
Awarded suppliers (15)
- Gilead Sciences Limited
- Merck Sharpe & Dohme (UK) Limited
- Janssen-Cilag Ltd
- Amarox Limited
- Tillomed Laboratories ltd
- Glenmark Pharmaceuticals Europe Limited
- Macleods Pharma UK Limited
- ViiV Healthcare
- Abbvie Ltd
- Mylan
- Mawdsley-Brooks & Co Ltd
- Lupin Healthcare (UK) Limited
- Teva UK Limited
- Dr.Reddy's Laboratories (UK) Limited
- Zentiva Pharma UK Ltd
Contact
Identifiers
Explore related tenders
External ID: cf-ocds-b5fd17-679c8a51-8d80-4a5a-a099-01eb80b9f1b8 • Added 5 October 2026